Table 1.

Expression of FTVII and Core2GlcNAcT-I in transfected CHO cells

Cell line and PSGL-1 constructAnti-sLex, MFIAnti-T antigen, MFI
CHO   
 None 405  
CHO FTVII   
 None 625 ND 
 Wild-type 604 ND 
 Tyr13/15Phe 589 ND 
 Thr14/17Ala 613 ND  
CHO Core2GlcNAcT-I/FTVII   
 None 718 143 
 Wild-type 775 192  
 Tyr13Phe 677 153 
 Tyr15Phe 921 127  
 Thr14Ala 807 189 
 Thr17Ala 811 214  
 Tyr13/15Phe 917 138 
 Thr14/17Ala 827 252 
Tyr13/15Phe;Thr14Gln/17Leu 756 239 
 Thr27/Ser211Ala 615 116 
Cell line and PSGL-1 constructAnti-sLex, MFIAnti-T antigen, MFI
CHO   
 None 405  
CHO FTVII   
 None 625 ND 
 Wild-type 604 ND 
 Tyr13/15Phe 589 ND 
 Thr14/17Ala 613 ND  
CHO Core2GlcNAcT-I/FTVII   
 None 718 143 
 Wild-type 775 192  
 Tyr13Phe 677 153 
 Tyr15Phe 921 127  
 Thr14Ala 807 189 
 Thr17Ala 811 214  
 Tyr13/15Phe 917 138 
 Thr14/17Ala 827 252 
Tyr13/15Phe;Thr14Gln/17Leu 756 239 
 Thr27/Ser211Ala 615 116 

Flow cytometry was used to measure the expression level of FTVII by binding of the anti-sLex mAb CSLEX-1. The expression level of Core2GlcNAcT-I was measured by binding of a mAb to the T antigen to enzymatically desialylated cells. Core-2O-glycans mask the epitopes for the mAb to the T antigen, resulting in decreased mAb binding to cell surfaces. The mAb binding was detected by binding of FITC-conjugated goat antimouse IgG/IgM. The data are represented as the MFI. MFI indicates mean fluorescence intensity; ND, not determined.